Skip to main content
Log in

Indinavir Crystallization and Urolithiasis

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

The crystallization of indinavir in synthetic urine at different pH values and indinavir concentrations was kinetically studied. It was found that precipitation time notably decreases at urinary pH values above 6.0. The effects of some products as potential crystallization inhibitors were studied. Some natural saponins such as escin and glycyrrhizic acid provoked a notable increase in the precipitation time of indinavir, this pointing out their possible use to prevent renal tubular solid deposition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Daudon, M., Estepa, L., Viard, J. P., Joly, D., Jungers, P.: Urinary stones in HIV-1-positive patients treated with indinavir. Lancet, 340, 1294 (1997).

    Google Scholar 

  2. Tashima, K. T., Horowitz, J. D., Rosen, S.: Indinavir nephropathy. N. Engl. J. Med., 336, 138 (1997).

    Google Scholar 

  3. Kopp, J. B., Miller, K. D., Mican, J. A., Feuerstein, I. M., Vaughan, E., Baker, C., Pannell, L. K., Falloon, J.: Crystalluria and urinary tract abnormalities associated with indinavir. Ann. Intern. Med., 127, 119 (1997).

    PubMed  Google Scholar 

  4. Berns, J. S., Cohen, R. M., Silverman, M., Turner, J.: Acute renal failure due to indinavir crystalluria and nephrolithiasis: Report of two cases. Am. J. Kidney Dis., 30, 558 (1997).

    PubMed  Google Scholar 

  5. Gentle, D. L., Stoller, M. L., Jarrett, T. W., Ward, J. F., Geib, K. S., Wood, A. F.: Protease inhibitor-induced urolithiasis. Urology, 50, 508 (1997).

    PubMed  Google Scholar 

  6. Bruce, R. G., Munch, L. C., Hoven, A. D., Jerauld, R. S., Greenburg, R., Porter, W. H., Rutter, P. W.: Urolithiasis associated with the protease inhibitor indinavir. Urology, 50, 513 (1997).

    PubMed  Google Scholar 

  7. Grases, F., Masarova, L., Söhnel, O., Costa-Bauzá, A.: Agglomeration of calcium oxalate monohydrate in synthetic urine. Br. J. Urol., 70, 240 (1992).

    PubMed  Google Scholar 

  8. Grases, F., Villacampa, A. I., Costa-Bauzá, A., Söhnel, O.: Uric acid calculi. Scanning Microsc. (in press)

  9. Grases, F., Conte, A., March, J. G., Genestar, C., Costa-Bauzá, A., Martin, M., Vallescar, R.: Epidemiology of urinary stone disease in the Balearic Islands Community. Int. Urol. Nephrol., 26, 145 (1994).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grases, F., Costa-Bauzá, A., García-González, R. et al. Indinavir Crystallization and Urolithiasis. Int Urol Nephrol 31, 23–29 (1999). https://doi.org/10.1023/A:1007111504518

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007111504518

Keywords

Navigation